Showing results (71-80 of 96) with videos related to
Sort By:
Pageof 10
British Journal of Cancer|August 1, 1993
Pharmacology and antitumour effects of intraportal pirarubicin on experimental liver metastasesL H Ramirez, J N Munck, C Bognel, et al.Journal of Medicinal Chemistry|January 1, 1989
Rationale for the synthesis and preliminary biological evaluation of highly active new antitumor nitrosoureido sugarsP Roger, C Monneret, J P Fournier, et al.Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetics and antitumor effects of mitoxantrone after intratumoral or intraarterial hepatic administration in rabbitsL H Ramirez, Z Zhao, P Rougier, et al.Bulletin Du Cancer|January 1, 1987
[High-doses chemotherapy followed by bone marrow autograft in the treatment of small cell bronchial cancer]J L Pico, D Baume, M Ostronoff, et al.Anticancer Research|May 6, 1998
Red blood cell glutathione levels before and during treatment with neoadjuvant chemotherapy cisplatin/5-fluorouracil in patients with head and neck squamous cell carcinomaL Massaad-Massade, C Domenge, S Rongeat, et al.Anticancer Research|September 1, 1986
Preliminary phase I clinical study and pharmacokinetics of (1,2-diaminocyclohexane) (isocitrato) platinum (II) or PHICA Gouyette, J P Ducret, P Caillé, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patientsM de Forni, G G Chabot, J P Armand, et al.Cancer Research|April 1, 1993
Chronopharmacology of high-dose busulfan in childrenG Vassal, D Challine, S Koscielny, et al.Cancer Research|October 1, 1990
Dose-dependent neurotoxicity of high-dose busulfan in children: a clinical and pharmacological studyG Vassal, A Deroussent, O Hartmann, et al.Carcinogenesis|July 1, 1993
Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinomaF Janot, L Massaad, V Ribrag, et al.Pageof 10